TrialInternational journal of radiation oncology, biology, physics2026

Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911.

Corey J Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.